March 26, 2024

Session Chair: Dr. Jérôme Van Biervliet (VIB - Managing Director)

Genetic discoveries at the basis of neurodegenerative brain disease therapies

Dr. Rosa Rademakers - VIB Center for Molecular Neurology – University of Antwerp

Pharma shifts: How to organise for Personal Medicines?

Ir. Bart Van Waeyenberge – EU CAR-T Program Lead, Board of Directors Janssen Pharmaceutica NV

From basic enzymology to new medicines

Prof. dr. Chris Schofield - Dep. Chemistry - University of Oxford